pirozadil has been researched along with clofibric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz González, JM; Marín Plaza, R; Varela de Seijas, JR | 1 |
| Cadierno Carpintero, M; Emeterio Reig, E; Soler Masana, JM | 1 |
| Azanza Perea, JR; Honorato Pérez, J | 1 |
2 trial(s) available for pirozadil and clofibric acid
| Article | Year |
|---|---|
[Clinical trial of a new drug for the treatment of atherosclerosis: pirozadil (722-D) (author's transl)].
Topics: Clinical Trials as Topic; Clofibric Acid; Coronary Disease; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Pyridines; Random Allocation | 1982 |
[A double blind study of the new hypolipidemic agent pirozadil (722-D) using patients with ischemic heart disease (author's transl)].
Topics: Aged; Clinical Trials as Topic; Clofibric Acid; Coronary Disease; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Male; Middle Aged; Pyridines; Random Allocation | 1982 |
1 other study(ies) available for pirozadil and clofibric acid
| Article | Year |
|---|---|
[Single-blind study of the efficacy of pirozadil versus alufibrate in the treatment of primary hyperlipoproteinemias].
Topics: Cholesterol; Clofibrate; Clofibric Acid; Drug Evaluation; Female; Humans; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Platelet Aggregation; Pyridines; Random Allocation | 1982 |